Success Metrics

Clinical Success Rate
93.2%

Based on 82 completed trials

Completion Rate
93%(82/88)
Active Trials
5(5%)
Results Posted
34%(28 trials)
Terminated
6(5%)

Phase Distribution

Ph not_applicable
14
13%
Ph phase_2
13
12%
Ph phase_3
20
18%
Ph phase_1
24
22%
Ph phase_4
35
32%

Phase Distribution

24

Early Stage

13

Mid Stage

55

Late Stage

Phase Distribution106 total trials
Phase 1Safety & dosage
24(22.6%)
Phase 2Efficacy & side effects
13(12.3%)
Phase 3Large-scale testing
20(18.9%)
Phase 4Post-market surveillance
35(33.0%)
N/ANon-phased studies
14(13.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.4%

82 of 96 finished

Non-Completion Rate

14.6%

14 ended early

Currently Active

5

trials recruiting

Total Trials

111

all time

Status Distribution
Active(7)
Completed(82)
Terminated(14)
Other(8)

Detailed Status

Completed82
unknown8
Withdrawn8
Terminated6
Recruiting5
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
111
Active
5
Success Rate
93.2%
Most Advanced
Phase 4

Trials by Phase

Phase 124 (22.6%)
Phase 213 (12.3%)
Phase 320 (18.9%)
Phase 435 (33.0%)
N/A14 (13.2%)

Trials by Status

completed8274%
enrolling_by_invitation11%
recruiting55%
unknown87%
withdrawn87%
not_yet_recruiting11%
terminated65%

Recent Activity

Clinical Trials (111)

Showing 20 of 111 trialsScroll for more
NCT07683793Phase 1

A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male Participants

Not Yet Recruiting
NCT06481306Phase 1

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Recruiting
NCT04248335Phase 4

Effect of Obesity on Proton Pump Inhibitors

Completed
NCT02467621Phase 4

Stress Ulcer Prophylaxis in the Intensive Care Unit

Completed
NCT07248722Not Applicable

Pantoprazole After Prophylactic Endoscopic Variceal Treatment

Enrolling By Invitation
NCT00713947Phase 4

Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control

Withdrawn
NCT06154226Phase 2

Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor

Completed
NCT07354230Phase 4

Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation Treated With DOACs

Completed
NCT07262736Phase 1

Pharmacokinetics of Clozapine and Norclozapine and the Effect of Pantoprazole

Completed
NCT04728516Phase 4

The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Recruiting
NCT06991348Phase 4

Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole

Recruiting
NCT06488001Phase 2

Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery

Recruiting
NCT05251233Phase 2

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Terminated
NCT06856447Phase 1

The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

Recruiting
NCT02685748Phase 2

Aspirin in Young Psychotic Patients

Completed
NCT03374800Phase 3

Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial

Completed
NCT03908593Phase 4

Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG

Unknown
NCT05915520Not Applicable

Baduanjin Program Effect on Geriatric Functional Dyspepsia

Unknown
NCT01776424Phase 3

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Completed
NCT04935112Phase 1

A Study to Explore the Effect of Acid-reducing Agents

Completed

Drug Details

Intervention Type
DRUG
Total Trials
111